Skip to main content
Clinical Trials/ACTRN12613001282774
ACTRN12613001282774
Completed
未知

An evaluation involving an in-lab assessment of a continuous positive airway pressure (CPAP) device for the treatment of Obstructive Sleep Apnea (OSA) along with changes in pressure, humidity and therapy modes to determine whether the device provides the same therapy and comfort as its predecessor and similar released products on the market.

Hanie Yee0 sites300 target enrollmentNovember 20, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Obstructive Sleep Apnea
Sponsor
Hanie Yee
Enrollment
300
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 20, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hanie Yee

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with OSA by a practicing sleep physician
  • AHI \> 5 from diagnostic night

Exclusion Criteria

  • Patients with a known history ofCerebrospinal fluid leak, abnormalities of the cribriform plate, head trauma and/or pneumocephalus
  • Patients with pathologically low blood pressure, pneumothorax, a previous history of pneumothorax, or for patients who have an increased risk of pneumothorax, such as those with bullous lung disease
  • Patient with bypassed upper airway
  • Other significant sleep disorder(s) (e.g. periodic leg movements, insomnia, central sleep apnea)
  • Patients with obesity hypoventilation syndrome or congestive heart failure
  • Patients that require supplemental oxygen with their CPAP device
  • Patients with implanted electronic medical devices (e.g. cardiac pacemakers)

Outcomes

Primary Outcomes

Not specified

Similar Trials